Professor Mark Lawler:

I will start. It is good to see Ms Hanna again.

Ms Hanna's question in relation to an innovation hub is a brilliant one. Yesterday, as part of the Northern Ireland Science Festival, I spoke specifically on that topic and said how Northern Ireland will be one of the great health hubs, particularly in relation to digital health. We already have people who are showing that they are they best in the world in this. It is a huge opportunity, but it is an opportunity that would be enhanced even further by collaborating with our colleagues down South. That is a win-win situation. We are very good in relation to small and medium-sized enterprises. In the South, it is more bigger companies. However, looking at working together and with the universities driving that research, it is really important.

To answer a second question and also to go to those of Deputy Brendan Smith, I am sorry about the loss of the Deputy's brother and I ask him to accept my sympathies. What is really important to realise is that research is no longer a luxury. In the past, people talked about research as being tagged onto this as something done by people who sit in ivory towers. That is no longer the case. Research is now an integral part of 21st century cancer care. The committee will have heard what Professor Lowery said. We would not have a HPV vaccine unless we had research to do that. The situation with cancer research is similar. We have stated in this report that if you do not have research, you do not have good clinical care. It is important to recognise that point.

I will now hand over to Professor Gallagher to cover some of the aspects in relation to publicising the research that Ms Hanna and Deputy Brendan Smith asked about.